Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MasterCard Inc (MA) vs McKesson Corporation (MCK) Price & Performance

MasterCard IncTrade
McKesson CorporationTrade

Price performance (Past 24H)

Key statistics

MasterCard Inc vs McKesson Corporation — how do they compare? MasterCard Inc trades at $574.4 (market cap $499.38B), while McKesson Corporation trades at $921.5 (market cap $106.14B). The key difference: MasterCard Inc is far larger — about 4.7× McKesson Corporation's market cap, and MasterCard Inc pays the higher dividend (0.61%). Which is the better fit depends on your goals — on Pluang, investors hold MasterCard Inc for 134 Days and McKesson Corporation for 74 Days on average.

MAMCK
Market Cap
$499.38B$106.14B
Volume
1,862,680794,405
Sector
FinancialsHealth
52-Week High
$599.86$995.69
52-Week Low
$471.55$725.17
Typical Hold Time
134 Days74 Days
Enterprise Value
$512.41B$112.67B
Dividend Yield
0.61%0.41%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MasterCard Inc

Mastercard (MA) trades at $574.76, up 1.44% with strong bullish technical signals and consistent earnings beats. The stock shows robust fundamentals with 46.3% net margins and 241.5% ROE, supported by growing institutional interest. Recent news highlights Mastercard's AI and digital payment initiatives, while analyst consensus remains strongly bullish with an $666.67 price target.

Outlook remains positive given earnings momentum and strategic positioning in digital payments, though competition from emerging payment technologies presents a key risk. The stock offers growth potential but requires monitoring of payment industry disruption and macroeconomic factors affecting consumer spending.

McKesson Corporation

McKesson (MCK) trades at $930.25, up 0.93% with strong bullish momentum after recent earnings beats and positive news flow. The stock shows robust technical strength with moving averages signaling bullish alignment and price trading near resistance at $926. Fundamentally, revenue growth accelerated to $359.1 billion in 2025 with consistent profitability, though thin margins remain a characteristic of the distribution business model. Recent catalyst includes the CVS Health partnership extension through 2032, reinforcing long-term revenue visibility.

Outlook remains positive with 81% analyst buy ratings and $956.43 consensus target suggesting 2.8% upside. Key opportunities include oncology/GLP-1 growth drivers and operational efficiency gains, while risks center on drug pricing pressure, policy uncertainty, and competitive threats. The company's improved cash flow generation and debt reduction support financial stability amid sector headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MA
63% Buy37% Sell
Avg holding period · 134 Days
MCK
40% Buy60% Sell
Avg holding period · 74 Days

Top news

Latest headlines on both assets

About MasterCard Inc

Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.

Read more on MA →

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK →